Lonza strengthens ADC offering with Synaffix acquisition
Lonza has acquired Synaffix B.V., a biotech company focused on commercializing its clinical-stage technology platform for the development of antibody drug conjugates (ADCs).
Archives for June 1, 2023
invoX Pharma increases investment in pHion Therapeutics to develop mRNA vaccines
invoX Pharma has completed a second tranche of investment of pHion Therapeutics, a next-generation mRNA vaccine company.
Avacta acquires rapid diagnostic test firm Coris Bioconcept
Avacta Group has acquired Coris Bioconcept, a European manufacturer of rapid diagnostic test kits.